MyMeds&Me CEO Andrew Rut writes for Applied Clinical Trials and reflects on the latest benchmark data on current drug safety practices from the team at Cutting Edge and asks, “Are Pharma Companies in Control of Their Pharmacovigilance Processes?”.
Read more on AppliedClinicalTrialsOnline.com
